BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17336297)

  • 1. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies.
    Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z
    Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.
    Brahimi K; Badell E; Sauzet JP; BenMohamed L; Daubersies P; Guérin-Marchand C; Snounou G; Druilhe P
    Infect Immun; 2001 Jun; 69(6):3845-52. PubMed ID: 11349050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii.
    Burns JM; Parke LA; Daly TM; Cavacini LA; Weidanz WP; Long CA
    J Immunol; 1989 Apr; 142(8):2835-40. PubMed ID: 2467942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.
    Ray P; Sahoo N; Singh B; Kironde FA
    Infect Immun; 1994 Jun; 62(6):2354-61. PubMed ID: 8188358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM; Majarian WR; Young JF; Daly TM; Long CA
    J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the antigens of invasive stages of Plasmodium yoelii and Plasmodium berghei].
    Jin LQ; Luo JM; Fu YC; Xu SE; Guo Y; Xie LC; Tsuboi T; Torii M
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(5):272-4. PubMed ID: 15108514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
    Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
    Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 70-kDa Triton X-114-soluble antigen of Plasmodium falciparum that contains interspecies-conserved epitopes.
    Ma HW; Ray P; Dhanda V; Das PK; Paliwal S; Sahoo N; Patra KP; Das LK; Singh B; Kironde FA
    Exp Parasitol; 1996 Aug; 83(3):322-34. PubMed ID: 8823249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
    Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
    Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
    Lougovskoi AA; Okoyeh NJ; Chauhan VS
    Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
    Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
    Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria.
    Chauhan VS; Chatterjee S; Johar PK
    Parasite Immunol; 1993 Apr; 15(4):239-42. PubMed ID: 7685076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.
    Locher CP; Tam LQ; Chang SP; McBride JS; Siddiqui WA
    Exp Parasitol; 1996 Oct; 84(1):74-83. PubMed ID: 8888734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s).
    Lucas B; Engels A; Camus D; Haque A
    Infect Immun; 1993 Nov; 61(11):4863-9. PubMed ID: 8104901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
    Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
    Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
    Calvo PA; Daly TM; Long CA
    Exp Parasitol; 1996 Jan; 82(1):54-64. PubMed ID: 8617331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.